Pier Capital’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Pier Capital’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-194,756	Closed	-$6.56M	–	137
2014 Q4	$6.56M	Sell	194,756 -1,613	-0.8%	-$57K	0.97%	61
2014 Q3	$6.88M	Sell	196,369 -2,251	-1%	-$77.2K	1.1%	30
2014 Q2	$6.53M	Sell	198,620 -18,381	-8%	-$629K	0.93%	65
2014 Q1	$8M	Sell	217,001 -1,227	-0.6%	-$45K	1.03%	38
2013 Q4	$8.38M	Sell	218,228 -57,800	-21%	-$1.82M	1.12%	30
2013 Q3	$7.56M	Buy	+276,028	New	+$6.54M	1.07%	30

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Pier Capital's WX Position: Q1 2015 in Review

Pier Capital sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 194,756 shares — an estimated $6.56M sold.

Pier Capital first reported a position in WX in Q3 2013 and held it in 6 quarters. The position peaked at $8.38M in Q4 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Pier Capital reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Pier Capital sold 194,756 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $6.56M.
Pier Capital first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 6 quarters.
Pier Capital's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $8.38M in Q4 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Pier Capital's 13F filing for Q1 2015, filed 14 May 2015.